JPWO2021071812A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021071812A5
JPWO2021071812A5 JP2022546590A JP2022546590A JPWO2021071812A5 JP WO2021071812 A5 JPWO2021071812 A5 JP WO2021071812A5 JP 2022546590 A JP2022546590 A JP 2022546590A JP 2022546590 A JP2022546590 A JP 2022546590A JP WO2021071812 A5 JPWO2021071812 A5 JP WO2021071812A5
Authority
JP
Japan
Prior art keywords
cr6r7
optionally substituted
occurrence
alkyl
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022546590A
Other languages
English (en)
Japanese (ja)
Other versions
JP7822940B2 (ja
JP2022551198A5 (https=
JP2022551198A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/054360 external-priority patent/WO2021071812A1/en
Publication of JP2022551198A publication Critical patent/JP2022551198A/ja
Publication of JP2022551198A5 publication Critical patent/JP2022551198A5/ja
Publication of JPWO2021071812A5 publication Critical patent/JPWO2021071812A5/ja
Application granted granted Critical
Publication of JP7822940B2 publication Critical patent/JP7822940B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022546590A 2019-10-07 2020-10-06 Kv1.3カリウムシェーカーチャネル遮断薬としてのアリールメチレン複素環式化合物 Active JP7822940B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962911652P 2019-10-07 2019-10-07
US62/911,652 2019-10-07
PCT/US2020/054360 WO2021071812A1 (en) 2019-10-07 2020-10-06 Arylmethylene heterocyclic compounds as kv1.3 potassium shaker channel blockers

Publications (4)

Publication Number Publication Date
JP2022551198A JP2022551198A (ja) 2022-12-07
JP2022551198A5 JP2022551198A5 (https=) 2024-05-15
JPWO2021071812A5 true JPWO2021071812A5 (https=) 2024-05-15
JP7822940B2 JP7822940B2 (ja) 2026-03-03

Family

ID=75436856

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022546590A Active JP7822940B2 (ja) 2019-10-07 2020-10-06 Kv1.3カリウムシェーカーチャネル遮断薬としてのアリールメチレン複素環式化合物

Country Status (11)

Country Link
US (1) US20220411367A1 (https=)
EP (1) EP4041228A4 (https=)
JP (1) JP7822940B2 (https=)
KR (1) KR20220079881A (https=)
CN (1) CN114727993B (https=)
AU (1) AU2020363360A1 (https=)
BR (1) BR112022006226A2 (https=)
CA (1) CA3157031A1 (https=)
IL (1) IL291869A (https=)
MX (1) MX2022004145A (https=)
WO (1) WO2021071812A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116782894A (zh) * 2020-10-06 2023-09-19 D.E.肖研究有限责任公司 作为Kv1.3钾Shaker通道阻断剂的内酰胺化合物
WO2025029769A1 (en) 2023-07-31 2025-02-06 Eli Lilly And Company Solid forms of a kv1.3 potassium shaker channel blockers and method of using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL208928B1 (pl) * 2001-04-16 2011-06-30 Pharmacopeia 3, 4-di-podstawione cyklobuten-1, 2-diony jako ligandy receptora CXC chemokiny
WO2008115118A1 (en) * 2007-03-21 2008-09-25 Innate Pharmaceuticals Ab Method and means for preventing and inhibiting type iii secretion in infections caused by gram-negative bacteria
TW201026708A (en) 2008-12-12 2010-07-16 Solvay Pharm Bv Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers
WO2013056153A1 (en) 2011-10-13 2013-04-18 Kung Charles Activators of pyruvate kinase m2 and methods of treating disease
CA2969295A1 (en) 2016-06-06 2017-12-06 Pfizer Inc. Substituted carbonucleoside derivatives, and use thereof as a prmt5 inhibitor
AU2017367086A1 (en) * 2016-11-29 2019-07-18 Epizyme, Inc. Compounds containing a sulfonic group as KAT inhibitors
US11529338B2 (en) * 2017-08-22 2022-12-20 Cedars-Sinai Medical Center Compositions and methods for treating cancer

Similar Documents

Publication Publication Date Title
JPWO2021071802A5 (https=)
JP6466348B2 (ja) スルファモイル−アリールアミドおよびb型肝炎を処置するための医薬品としてのその使用
JP2020528889A5 (https=)
JP2013530236A5 (https=)
JP2013525433A5 (https=)
JP2023164918A5 (https=)
JP2015502387A5 (https=)
JPH09509171A (ja) 免疫抑制活性を有するミコフェノール酸の4−アミノ誘導体
JPWO2021071821A5 (https=)
JP2025514786A5 (https=)
JPWO2021071812A5 (https=)
JPWO2021071806A5 (https=)
JPWO2020041741A5 (https=)
JPWO2023072240A5 (https=)
JPWO2021071803A5 (https=)
JPWO2020102576A5 (https=)
JPWO2023072257A5 (https=)
JPWO2020163778A5 (https=)
JPWO2021207530A5 (https=)
JPWO2021092246A5 (https=)
JPWO2020033488A5 (https=)
JPWO2021262812A5 (https=)
JPWO2023150150A5 (https=)
JPWO2019213470A5 (https=)
JPWO2021071832A5 (https=)